Updated:
ZS Associates
ZS Associates was founded in 1983 by Andris Zoltners and Prabha Sinha, two Northwestern University professors who built a sales-force analytics practice...
ZS Associates
ZS Associates was founded in 1983 by Andris Zoltners and Prabha Sinha, two Northwestern University professors who built a sales-force analytics practice that became the anchor of a global consultancy. The firm retains its founding partners' emphasis on data-driven commercial strategy, with a governance structure that keeps the founders' estate as a controlling shareholder. The firm's asset-management arm, ZS Capital, deploys capital across healthcare analytics, enterprise SaaS, and AI/ML. Known direct investments include Definitive Healthcare (a healthcare data platform taken public in 2021) and Narrative Science (an AI natural-language generation company acquired in 2018). ZS Associates operates in North America and Europe, with additional offices in Basel and Athens. The firm employs over 13,000 professionals globally, though its wealth-origin source is not publicly disclosed. ZS Associates has not published a recent fundraise or deployment timeline; its investment activity is primarily captured through portfolio-company press releases. ZS Associates differs from most consulting firms by housing an internally funded growth-equity arm alongside its operational consulting practice. This dual structure allows ZS Capital to draw on the firm's proprietary data and industry access for deal sourcing, while the consulting side generates recurring revenues that buffer the investment portfolio.
General information
Firm type
Asset Manager
Year founded
1983
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Evanston
Corporate office
Evanston, IL, United States
Additional offices
Chicago · Athens · Basel
Principals
Andris Zoltners
Co-Founder
Prabha Sinha
Co-Founder
Sector focus
Frequently asked questions
Who controls the wealth behind ZS Associates?
ZS Associates remains privately held, with co-founders Andris Zoltners and Prabha Sinha and their families as controlling shareholders. The firm does not disclose a single-family-office structure; its wealth-origin is the founders' equity in the consulting business.
How does ZS Capital source deal flow?
ZS Capital sources deals through the consulting firm's 13,000-plus professionals, who work directly with pharmaceutical, healthcare, and technology clients. This operational access provides proprietary insights into vendor needs and market gaps, distinct from traditional venture capital sourcing.
Does ZS Associates invest only through direct deals or also via fund commitments?
ZS Capital primarily makes direct equity investments in growth-stage companies, often leading or co-leading rounds. The firm does not publicly report fund-of-funds or GP-limited-partner commitments.
What investment stages does ZS Capital target?
ZS Capital targets growth-stage and late-stage investments, typically in companies that have demonstrated product-market fit and are scaling commercial operations. The firm avoids early-seed or pre-revenue deals.
Are ZS Associates' philanthropic activities separate from its investment arm?
The ZS Foundation operates independently from ZS Capital, focusing on global health and education grants (per the foundation's website). The foundation's funding is sourced from the consulting firm's profits, not the investment portfolio.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: